Phosphoinositide 3-kinase in health and disease Volume 1

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...

Deskribapen osoa

Xehetasun bibliografikoak
Erakunde egilea: SpringerLink (Online service)
Beste egile batzuk: Rommel, Christian, Vanhaesebroeck, Bart, Vogt, Peter K.
Formatua: Electronic Resource
Hizkuntza:English
Argitaratua: Berlin, Heidelberg Springer 2011.
Saila:Current Topics in Microbiology and Immunology 346
Gaiak:
Sarrera elektronikoa:Available for University of the Philippines Diliman via SpringerLink. Click here to access